Growth hormone used to control intractable bleeding caused by radiation-induced gastritis

World J Gastroenterol. 2015 Aug 21;21(31):9453-6. doi: 10.3748/wjg.v21.i31.9453.

Abstract

Intractable bleeding caused by radiation-induced gastritis is rare. We describe a 69-year-old man with intractable hemorrhagic gastritis induced by postoperative radiotherapy for the treatment of esophageal carcinoma. Although anti-secretory therapy with or without octreotide was initiated for hemostasis over three months, melena still occurred off and on, and the patient required blood transfusions to maintain stable hemoglobin. Finally growth hormone was used in the treatment of hemorrhage for two weeks, and hemostasis was successfully achieved. This is the first report that growth hormone has been used to control intractable bleeding caused by radiation-induced gastritis.

Keywords: Growth hormone; Radiation-induced gastritis; Upper gastrointestinal bleeding.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy*
  • Endoscopy, Gastrointestinal
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / radiotherapy*
  • Esophageal Squamous Cell Carcinoma
  • Gastritis / diagnosis
  • Gastritis / drug therapy*
  • Gastritis / etiology
  • Gastrointestinal Hemorrhage / diagnosis
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Growth Hormone / therapeutic use*
  • Hemostatics / therapeutic use*
  • Humans
  • Male
  • Radiation Injuries / diagnosis
  • Radiation Injuries / drug therapy*
  • Radiation Injuries / etiology
  • Radiotherapy / adverse effects
  • Treatment Outcome

Substances

  • Hemostatics
  • Growth Hormone